Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay. by Winstone, N, Guimarães-Walker, A, Roberts, J, Brown, D, Loach, V, Goonetilleke, N, Hanke, T, Mcmichael, A

Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption. by Yang, H, Guimarães-Walker, A, Hibbs, S, Dong, T, Stacey, A, Borrow, P, Hanke, T, Davenport, M, McMichael, A, Dorrell, L

Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects. by Howles, S, Guimarães-Walker, A, Yang, H, Hancock, G, di Gleria, K, Tarragona-Fiol, T, Hayes, P, Gilmour, J, Bridgeman, A, Hanke, T, McMichael, A, Dorrell, L

EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium. by Bart, P, Goodall, R, Barber, T, Harari, A, Guimaraes-Walker, A, Khonkarly, M, Sheppard, N, Bangala, Y, Frachette, M, Wagner, R, Liljeström, P, Kraehenbuhl, J, Girard, M, Goudsmit, J, Esteban, M, Heeney, J, Sattentau, Q, McCormack, S, Babiker, A, Pantaleo, G, Weber, J

Corrigendum to "Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to in... by Guimarães-Walker, A, Mackie, N, McCormack, S, Hanke, T, Schmidt, C, Gilmour, J, Barin, B, McMichael, A, Weber, J, Legg, K, Babiker, A, Hayes, P, Gotch, F, Smith, C, Dally, L, Dorrell, L, Cebere, I, Kay, R, Winstone, N, Moore, S, Goonetilleke, N, Fast, P

Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 speci... by Guimarães-Walker, A, Mackie, N, McCormack, S, Hanke, T, Schmidt, C, Gilmour, J, Barin, B, McMichael, A, Weber, J, Legg, K, Babiker, A, Hayes, P, Gotch, F, Smith, C, Dally, L, Dorrell, L, Cebere, I, Kay, R, Winstone, N, Moore, S, Goonetilleke, N, Fast, P

Corrigendum to " Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to i... by Guimarães-Walker, A, Mackie, N, McCormack, S, Hanke, T, Schmidt, C, Gilmour, J, Barin, B, McMichael, A, Weber, J, Legg, K, Babiker, A, Hayes, P, Gotch, F, Smith, C, Dally, L, Dorrell, L, Cebere, I, Kay, R, Winstone, N, Moore, S, Goonetilleke, N, Fast, P

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 speci... by Guimaraes-Walker, A, Mackie, N, McCormack, S, Hanke, T, Schmidt, C, Gilmour, J, Barin, B, McMichael, A, Weber, J, Legg, K, Babiker, A, Hayes, P, Gotch, F, Smith, C, Dally, L, Dorrell, L, Cebere, I, Kay, R, Winstone, N, Moore, S, Goonetilleke, N, Fast, P, Grp, I

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and mo... by Goonetilleke, N, Moore, S, Dally, L, Winstone, N, Cebere, I, Mahmoud, A, Pinheiro, S, Gillespie, G, Brown, D, Loach, V, Roberts, J, Guimaraes-Walker, A, Hayes, P, Loughran, K, Smith, C, De Bont, J, Verlinde, C, Vooijs, D, Schmidt, C, Boaz, M, Gilmour, J, Fast, P, Dorrell, L, Hanke, T, Mcmichael, A